Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christina Barkauskas"'
Autor:
Jeroen Molinger, John Whittle, Henrik Endeman, David MacLeod, Rajan Gupta, Marat Fudim, Krista L. Haines, Christina Barkauskas, Zachary Healy, Paul Wischmeyer, Jan Bakker
Publikováno v:
Frontiers in Anesthesiology, Vol 3 (2024)
BackgroundMuscle wasting is a common finding in critically ill patients associated with increased days of mechanical ventilation in the ICU. Muscle wasting and associated morphological changes are hallmarks of ICU-acquired weakness. Muscle wasting ca
Externí odkaz:
https://doaj.org/article/07396a54023c4250bf13e957a840efce
Autor:
Jeroen Molinger, John Whittle, Susie Cha, David MacLeod, Marat Fudim, Luis Ulloa, Christina Barkauskas, Zachary Healy, Krista L. Haines, Rajan T. Gupta, Henrik Endeman, Mathieu van der Jagt, Diederik Gommers, Jan Bakker, Paul E. Wischmeyer
Publikováno v:
Frontiers in Anesthesiology, Vol 3 (2024)
IntroductionThe COVID-19 pandemic brought unprecedented challenges to healthcare systems worldwide, particularly the often challenging physical recovery from critical illness. Among the myriad complications faced by these patients, ICU-acquired weakn
Externí odkaz:
https://doaj.org/article/c1678bfd796f45509c3428e33d0f7e17
Autor:
Maryam Keshtkar-Jahromi, Kevin J. Anstrom, Christina Barkauskas, Samuel M. Brown, Eric S. Daar, William Fischer, Kevin W. Gibbs, Elizabeth S. Higgs, Michael D. Hughes, Prasanna Jagannathan, Lisa LaVange, Christopher J. Lindsell, Seema U. Nayak, Roger Paredes, Mahesh Parmar, Ithan D. Peltan, Michael Proschan, Matthew S. Shotwell, David M. Vock, Tammy Yokum, Stacey J. Adam
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Accelerating COVID-19 Treatment Interventions and Vaccines (ACTIV) was initiated by the US government to rapidly develop and test vaccines and therapeutics against COVID-19 in 2020. The ACTIV Therapeutics-Clinical Working Group selected ACTIV trial t
Externí odkaz:
https://doaj.org/article/7e2590f8d0ee49e1b99ef50a2cfc40d2
Autor:
Hagir B. Suliman, Zachary Healy, Fabio Zobi, Bryan D. Kraft, Karen Welty-Wolf, Joshua Smith, Christina Barkauskas, Claude A. Piantadosi
Publikováno v:
iScience, Vol 25, Iss 1, Pp 103535- (2022)
Summary: The preclinical model of bleomycin-induced lung fibrosis is useful to study mechanisms related to human pulmonary fibrosis. Using BLM in mice, we find low HO-1 expression. Although a unique Rhenium-CO-releasing molecule (ReCORM) up-regulates
Externí odkaz:
https://doaj.org/article/59b5ccf9de1247a680363d09e5bf4f49
Publikováno v:
Annals of Internal Medicine. 176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3875c72cdcbe90c55c9e67143b700ad0
https://doi.org/10.7326/l22-0456
https://doi.org/10.7326/l22-0456
Autor:
Stephen P Bergin, Roy F Chemaly, Radha Duttagupta, Robert Bigelow, Sanjeet S Dadwal, Joshua A Hill, Yeon Joo Lee, Ghady Haidar, Alfred Luk, Alexander Christian Drelick, Peter V Chin-Hong, Esther Benamu, Thomas Davis, Olivia Wolf, Micah T McClain, Eileen K Maziarz, Deng Madut, Armando Bedoya, Daniel L Gilstrap, Jamie Todd, Christina Barkauskas, Alfredo Puing, Amy Spallone, Brittany J McDowell, Dayana Shariff, Elizabeth Salsgiver, Deepa D Nanayakkara, Fareed Khawaja, Genovefa Papanicolaou, Jack Spagnoletti, Marico English, Monica Fung, Patrick Russel, Sarah Ibrahimi, Shraddha Pandey, Suzanne Adams, Wendy Liang, Elena Nemirovich-Danchenko, Mona Mughar, Sudeb Dalai, Yuen Cho, Asim A Ahmed, Desiree Hollemon, David K Hong, Marla Lay Vaughn, Tim Blauwkamp, Zivjena Vucetic, Rina Romano, Vance G Fowler, Thomas L Holland
Publikováno v:
Open Forum Infectious Diseases. 9
Background Pneumonia is the most common infectious cause of morbidity and excess mortality complicating hematopoietic cell transplantation (HCT) and treatment of hematologic malignancy. Standard bronchoscopic and noninvasive microbiologic testing ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d06e550bb8b633644a1f3092917ee36
https://doi.org/10.1093/ofid/ofac492.597
https://doi.org/10.1093/ofid/ofac492.597
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19:A Randomized Controlled Trial
Autor:
Christina, Barkauskas, Eleftherios, Mylonakis, Garyfallia, Poulakou, Barnaby E, Young, David M, Vock, Lianne, Siegel, Nicole, Engen, Greg, Grandits, Nilima R, Mosaly, Andrew M, Vekstein, Ralph, Rogers, Fadi, Shehadeh, Matthew, Kaczynski, Evangelia K, Mylona, Konstantinos N, Syrigos, Vasiliki, Rapti, David C, Lye, Diong Shiau, Hui, Lindsay, Leither, Kirk U, Knowlton, Mamta K, Jain, Rubria, Marines-Price, Alice, Osuji, J Scott, Overcash, Ioannis, Kalomenidis, Zafeiria, Barmparessou, Michael, Waters, Karla, Zepeda, Peter, Chen, Sam, Torbati, Francis, Kiweewa, Nicholus, Sebudde, Eyad, Almasri, Alyssa, Hughes, Sanjay R, Bhagani, Alison, Rodger, Uriel, Sandkovsky, Robert L, Gottlieb, Eriobu, Nnakelu, Barbara, Trautner, Vidya, Menon, Joseph, Lutaakome, Michael, Matthay, Philip, Robinson, Konstantinos, Protopapas, Nikolaos, Koulouris, Ivan, Kimuli, Amiran, Baduashvili, Dominique L, Braun, Huldrych F, Günthard, Srikanth, Ramachandruni, Robert, Kidega, Kami, Kim, Timothy J, Hatlen, Andrew N, Phillips, Daniel D, Murray, Tomas O, Jensen, Maria L, Padilla, Evan X, Accardi, Katy, Shaw-Saliba, Robin L, Dewar, Marc, Teitelbaum, Ven, Natarajan, Sylvain, Laverdure, Helene C, Highbarger, M Tauseef, Rehman, Susan, Vogel, David, Vallée, Page, Crew, Negin, Atri, Adam J, Schechner, Sarah, Pett, Fleur, Hudson, Jonathan, Badrock, Giota, Touloumi, Samuel M, Brown, Wesley H, Self, Crystal M, North, Adit A, Ginde, Christina C, Chang, Anthony, Kelleher, Stephanie, Nagy-Agren, Shikha, Vasudeva, David, Looney, Hien H, Nguyen, Adriana, Sánchez, Amy C, Weintrob, Birgit, Grund, Shweta, Sharma, Cavan S, Reilly, Roger, Paredes, Agnieszka, Bednarska, Norman P, Gerry, Abdel G, Babiker, Victoria J, Davey, Annetine C, Gelijns, Elizabeth S, Higgs, Virginia, Kan, Gail, Matthews, B Taylor, Thompson, Philippe, Legenne, Richa, Chandra, H Clifford, Lane, James D, Neaton, Richard, Williams
Publikováno v:
ACTIV-3/TICO Study Group*, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2022, ' Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial ', Annals of Internal Medicine, vol. 175, no. 9, pp. 1266-1274 . https://doi.org/10.7326/M22-1503
BACKGROUND: Ensovibep (MP0420) is a designed ankyrin repeat protein, a novel class of engineered proteins, under investigation as a treatment of SARS-CoV-2 infection. OBJECTIVE: To investigate if ensovibep, in addition to remdesivir and other standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d142eddc0f692abd7c33d99b51bb4e
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
https://vbn.aau.dk/da/publications/828dfc6c-d4d0-47b8-a749-9cc4901459a8
Autor:
David G, Mummy, Elianna A, Bier, Ziyi, Wang, Jennifer, Korzekwinski, Lake, Morrison, Christina, Barkauskas, H Page, McAdams, Robert M, Tighe, Bastiaan, Driehuys, Joseph G, Mammarappallil
Publikováno v:
Radiology. 301(1)
Background Recent studies demonstrate that antifibrotic drugs previously reserved for idiopathic pulmonary fibrosis (IPF) may slow progression in other interstitial lung diseases (ILDs), creating an urgent need for tools that can sensitively assess d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb0cfa02774ca1a1d2970957a532185b
https://pubmed.ncbi.nlm.nih.gov/34313476
https://pubmed.ncbi.nlm.nih.gov/34313476